AI In Medical Writing Market Size 2025-2029
The ai in medical writing market size is forecast to increase by USD 785.0 million, at a CAGR of 12.9% between 2024 and 2029.
The global AI in medical writing market is shaped by the escalating volume and complexity of data generated throughout the drug development lifecycle. The proliferation of data from intricate clinical trial designs and real-world evidence sources has rendered traditional manual documentation methods inefficient. This creates a critical need for intelligent automation, particularly using natural language processing and generation for ai in clinical trials. These systems can process immense datasets, identify trends, and generate preliminary drafts of tables, listings, and narrative summaries. This capability enhances efficiency, supporting the goals of generative ai in personalized medicine and improving the consistency of final documents. The adoption of these technologies is central to managing the modern data-driven pharmaceutical landscape.A primary trend involves the strategic shift toward developing and implementing domain-specific large language models. Unlike general-purpose models, these specialized LLMs are trained on curated biomedical literature and clinical trial data, offering a deeper understanding of medical terminology and regulatory guidelines. This targeted training makes them more accurate and contextually relevant, a key factor in applied ai in healthcare. However, ensuring data privacy and security in this highly regulated environment presents a formidable challenge. Integrating third-party AI platforms, especially cloud-based systems, introduces significant compliance risks related to sensitive patient data and proprietary corporate information. This necessitates robust security protocols, which can influence the adoption of ai writing assistant software.
What will be the Size of the AI In Medical Writing Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The evolution of domain-specific llm training is central to advancing AI's role in medical writing, moving beyond general-purpose models to those fine-tuned on curated biomedical literature for enhanced scientific accuracy. This specialization enables more reliable ai-powered content creation, which is essential for complex clinical trial documentation. The focus is on generating text that is not only coherent but also contextually relevant and compliant with industry standards, supporting critical processes in generative ai in personalized medicine.Hyper-automation workflows are becoming increasingly integral, targeting high-volume, repetitive tasks such as pharmacovigilance reporting and the generation of patient safety narratives. This approach allows organizations to achieve significant efficiency gains while mitigating the risks associated with AI in more interpretive writing. The integration of robotic process automation with more advanced AI is creating a seamless environment for managing structured documentation from end to end. This is a key component of ai for healthcare payer systems.The implementation of retrieval-augmented generation (RAG) is a critical technical development aimed at addressing the challenge of AI-generated fabrications. By compelling the AI to base its responses on a specific, curated set of source documents, RAG enhances the verifiability of generated content. This is crucial for maintaining the integrity of regulatory submission documents and ensuring that all claims are traceable to source data, a foundational requirement for ai-powered clinical decision support.
How is this AI In Medical Writing Industry segmented?
The ai in medical writing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Application
- Regulatory writing
- Scientific publications
- Medical communications
- Others
- Technology
- LLMs and generative AI
- NLP
- Machine learning
- Robotic process automation
- End-user
- Pharmaceutical companies
- Biotechnology companies
- Contract research organizations
- Others
- Geography
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- South America
- Middle East and Africa
- Rest of World (ROW)
By Application Insights
The regulatory writing segment is estimated to witness significant growth during the forecast period.
In the regulatory writing segment, AI is having a profound impact by addressing the complexity and scale associated with documents for health authority submissions. This application is critical, as documents like Clinical Study Reports and Common Technical Document modules are foundational to gaining market approval. AI platforms function as specialized assistants, automating time-consuming and repetitive tasks with high precision. This is particularly relevant in markets that represent over 5.63% of the growth opportunity where efficiency is key. They can automate the population of text and tables in reports by directly pulling data from clinical databases.
A key function of AI in this segment is maintaining internal consistency across thousands of pages in a submission package, checking for uniform terminology and data. These tools are trained on specific regulatory guidelines to ensure that generated content adheres to required templates. The technology also automates the generation of patient safety narratives by processing adverse event data. This approach accelerates drafting and quality control, allowing human experts to focus on data interpretation and scientific argumentation, thereby enhancing the strategic value of the submission.
Request Free Sample
The Regulatory writing segment was valued at USD 63.60 million in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 36.6% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
North America, led by the United States, stands as the dominant and most mature market for AI in medical writing. This leadership is supported by substantial investment in pharmaceutical R&D, the presence of major biopharmaceutical companies, and a vibrant tech ecosystem. The high concentration of research activities in North America creates a massive demand for medical writing services to support numerous clinical trials and regulatory submissions. The need to improve efficiency and reduce drug development costs is a powerful incentive for AI adoption, particularly in niche applications that constitute around 3.8% of the global market.
The region also benefits from its status as a global hub for AI research and commercialization, facilitating close collaboration between the pharmaceutical and tech sectors. This proximity leads to the development of AI tools specifically tailored for life sciences. The influential role of regulatory bodies, which are actively exploring AI in drug development, encourages industry players to invest in and pilot AI-based writing tools. Furthermore, a robust venture capital landscape in North America ensures a continuous pipeline of innovation, driving competition and advancing AI capabilities in medical writing across the region.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global AI in medical writing market is witnessing exponential growth, driven by the adoption of AI-powered platforms for medical writing. These solutions are revolutionizing the industry by enabling the automation of clinical study report generation and offering sophisticated AI-powered regulatory writing software. A key technological enabler is the use of domain-specific LLMs for medical communications, which excel at tasks like the AI-driven summarization of clinical data and natural language generation for patient narratives. Furthermore, the integration of retrieval-augmented generation for scientific accuracy is enhancing the quality of AI-assisted scientific publication authoring. This technological shift is also proving invaluable for managing AI in decentralized clinical trials documentation, streamlining processes that were once manually intensive.A significant focus area is leveraging generative AI for regulatory submissions, creating a pathway toward intelligent automation for submission-ready documents. The market is seeing increased demand for tools specializing in automating common technical document creation and AI tools for ICH E3 structure guidelines. This includes critical applications such as using AI for investigational new drug applications and automating periodic safety update reports. The trend of hyper-automation in pharmacovigilance reporting and incorporating real-world evidence for regulatory documents is also gaining traction. However, ensuring GXP compliance for AI systems and developing robust strategies for mitigating AI-generated fabrications in reports remain paramount for successful implementation. This extends to the careful oversight of AI generation of patient-facing materials to ensure accuracy and clarity.
What are the key market drivers leading to the rise in the adoption of AI In Medical Writing Industry?
- The escalating volume and complexity of clinical and real-world data is a primary driver for the adoption of AI in the medical writing market.
The exponential increase in the volume and complexity of data throughout the drug development lifecycle is a key factor driving market expansion. The modern pharmaceutical landscape is characterized by a data deluge from intricate clinical trial designs, the integration of real-world evidence, and the proliferation of high-throughput technologies. Traditional manual data interpretation and documentation are no longer sustainable, creating a critical need for intelligent automation. AI platforms, especially those using natural language processing, offer a viable solution by processing and structuring immense datasets to generate coherent, compliant, and scientifically sound narratives for documents like clinical study reports. A significant portion of the growth opportunity, accounting for 36.65%, is concentrated in geographies with high research and development activity, where managing this data is paramount.The biopharmaceutical industry operates under immense pressure to reduce the protracted timelines and exorbitant costs associated with bringing new therapeutics to market. The process from discovery to regulatory approval can span over a decade and cost billions, with a significant portion consumed by the clinical trial and regulatory submission phases. Medical and regulatory writing represents a critical, yet often rate-limiting, step. AI presents a transformative opportunity to decompress this timeline by automating many of the most labor-intensive tasks in medical writing, such as the generation of patient safety narratives and the population of standardized forms. This automation frees highly skilled medical writers to focus on more strategic and interpretive aspects of the submission, such as articulating the benefit-risk profile or responding to complex regulatory queries.
What are the market trends shaping the AI In Medical Writing Industry?
- The development and adoption of domain-specific large language models for medical writing is a key upcoming market trend.
A predominant trend is the strategic shift from general-purpose large language models toward the development and implementation of domain-specific models. While foundational models have demonstrated impressive general capabilities, their application in the highly specialized field of medical writing reveals limitations in understanding complex medical terminology and regulatory guidelines. In response, the industry is seeing a surge in specialized LLMs trained exclusively on curated biomedical literature, clinical trial data, and regulatory submission archives. This targeted training provides the models with a deeper subject matter understanding, enabling them to generate more accurate and contextually relevant content. This trend is particularly relevant in markets that contribute over 31.4% to the global landscape, where precision is paramount. This evolution is key for applications like generative ai in clinical trial documentation.Another significant market trend is the evolution of AI in medical writing from standalone point solutions to deeply integrated features within comprehensive, end-to-end platforms for clinical trial and regulatory information management. Initially, AI tools were often offered as separate applications for single tasks, creating workflow inefficiencies. The current trend is to embed AI capabilities directly into the platforms that medical writers and regulatory professionals already use daily. This integration creates a seamless, unified workflow where AI-powered assistance is available at every stage of the document lifecycle. This holistic integration ensures the AI works with current, validated source data, enhancing accuracy and collaboration. Such integrated systems are crucial for ai-powered clinical decision support and managing the complexities of modern drug development.
What challenges does the AI In Medical Writing Industry face during its growth?
- Ensuring data privacy and security in a highly regulated environment is a key challenge affecting the growth of the AI in medical writing industry.
A formidable challenge impeding widespread adoption is the paramount need to ensure the privacy and security of sensitive patient data and proprietary corporate information. The drug development process is governed by strict regulations like HIPAA and GDPR, and medical writing involves handling unblinded clinical trial data and confidential intellectual property. Integrating third-party AI platforms, particularly cloud-based ones, introduces significant compliance risks. Companies are cautious about transmitting sensitive data to external servers or processing it through models with non-transparent data handling protocols. This concern is significant in markets that represent over 22.52% of the global opportunity, where regulatory scrutiny is high. This creates a strong demand for on-premise or private cloud solutions, which can be resource-intensive to maintain.The integration of AI into the creation of documents that form the basis for regulatory approval presents a host of complex regulatory and ethical challenges that currently lack clear resolution. Agencies like the FDA and EMA have not yet issued definitive guidance on using generative AI in submission documents, creating uncertainty for sponsors. Unanswered questions regarding authorship, accountability, and data integrity are significant hurdles. For instance, determining who is legally and ethically accountable for an AI-generated error is a non-trivial question, as regulatory submissions are legal attestations. Without clear guidance, companies risk unexpected regulatory scrutiny or even submission rejection if their use of AI is deemed to have compromised the integrity of the documentation.
Exclusive Customer Landscape
The ai in medical writing market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the ai in medical writing market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, ai in medical writing market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
AINGENS - The offering includes an AI-powered automation platform engineered to generate submission-ready regulatory documents. The system focuses on streamlining the creation of compliant documentation for the life sciences sector.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- AINGENS
- Artos
- Cactus Communications Pvt. Ltd.
- Certara Inc.
- CopyAI Inc.
- DeepL SE
- GENINVO
- ICON plc
- Insilico Medicine
- IQVIA Holdings Inc.
- Litmap Ltd.
- OpenAI
- Oracle Corp.
- Parexel International Corp.
- SAS Institute Inc.
- Scite LLC
- Syneos Health
- TrialAssure
- Veeva Systems Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Ai In Medical Writing Market
In April 2024, Veeva Systems announced the Veeva AI Partner Program to make it easier for life sciences companies to adopt specialized AI solutions that work seamlessly with Veeva's cloud applications.In February 2024, Certara Inc. announced the acquisition of Applied Biomath, a provider of modeling and simulation software for drug development, a move aimed at enhancing its AI and machine learning capabilities to support biosimulation and regulatory science.In March 2024, Anthropic, a competitor to OpenAI, launched its Claude 3 model family, with the most powerful model, Opus, showing near-human levels of comprehension on complex tasks and superior performance on scientific knowledge benchmarks, making it highly suitable for medical writing applications.
Research Analyst Overview
The global AI in medical writing market reflects a dynamic shift towards process optimization, where technologies like natural language generation are fundamental to clinical study report automation and the assembly of complex regulatory submission documents. Hyper-automation workflows are increasingly applied to unstructured data processing and comprehensive biomedical literature analysis, enhancing the creation of clinical trial documentation. This evolution in ai-powered content creation is reshaping how clinical data summarization and medical terminology recognition are performed. Industry analyses indicate an expected 35% rise in the adoption of intelligent document automation tools to improve consistency and reduce manual authoring efforts in producing submission-ready documents.Emphasis is concurrently placed on governance and validation to ensure regulatory alignment, with a focus on developing GXP compliant AI systems and executing robust AI model validation. The use of domain-specific LLM training and retrieval-augmented generation is critical for maintaining scientific accuracy in AI and mitigating risks associated with AI-generated fabrications. These advanced systems facilitate regulatory compliance automation for drafting common technical document modules and patient safety narratives. Moreover, the technology is pivotal for pharmacovigilance reporting and ensuring automated consistency checks across investigational new drug applications and periodic safety update reports, all while adhering to ICH E3 structure guidelines.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled AI In Medical Writing Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
308
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 12.9%
|
|
Market growth 2024-2029
|
USD 785.0 million
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
12.0%
|
|
Key countries
|
US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Israel, South Africa, Turkey
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this AI In Medical Writing Market Research and Growth Report?
- CAGR of the AI In Medical Writing industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, APAC, South America, Middle East and Africa
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the ai in medical writing market growth of industry companies
We can help! Our analysts can customize this ai in medical writing market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global AI In Medical Writing Market 2019 - 2023
- Historic Market Size - Data Table on Global AI In Medical Writing Market 2019 - 2023 ($ billion)
- 5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ billion)
- 5.3 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ billion)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Five Forces Analysis
- 6 Five Forces Analysis
- 6.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 6.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 6.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 6.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 6.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 6.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 6.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
7 Market Segmentation by Application
- 7 Market Segmentation by Application
- 7.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 7.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 7.3 Regulatory writing - Market size and forecast 2024-2029
- Chart on Regulatory writing - Market size and forecast 2024-2029 ($ billion)
- Data Table on Regulatory writing - Market size and forecast 2024-2029 ($ billion)
- Chart on Regulatory writing - Year-over-year growth 2024-2029 (%)
- Data Table on Regulatory writing - Year-over-year growth 2024-2029 (%)
- 7.4 Scientific publications - Market size and forecast 2024-2029
- Chart on Scientific publications - Market size and forecast 2024-2029 ($ billion)
- Data Table on Scientific publications - Market size and forecast 2024-2029 ($ billion)
- Chart on Scientific publications - Year-over-year growth 2024-2029 (%)
- Data Table on Scientific publications - Year-over-year growth 2024-2029 (%)
- 7.5 Medical communications - Market size and forecast 2024-2029
- Chart on Medical communications - Market size and forecast 2024-2029 ($ billion)
- Data Table on Medical communications - Market size and forecast 2024-2029 ($ billion)
- Chart on Medical communications - Year-over-year growth 2024-2029 (%)
- Data Table on Medical communications - Year-over-year growth 2024-2029 (%)
- 7.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 7.7 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
8 Market Segmentation by Technology
- 8 Market Segmentation by Technology
- 8.1 Market segments
- Chart on Technology - Market share 2024-2029 (%)
- Data Table on Technology - Market share 2024-2029 (%)
- 8.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
- 8.3 LLMs and generative AI - Market size and forecast 2024-2029
- Chart on LLMs and generative AI - Market size and forecast 2024-2029 ($ billion)
- Data Table on LLMs and generative AI - Market size and forecast 2024-2029 ($ billion)
- Chart on LLMs and generative AI - Year-over-year growth 2024-2029 (%)
- Data Table on LLMs and generative AI - Year-over-year growth 2024-2029 (%)
- 8.4 NLP - Market size and forecast 2024-2029
- Chart on NLP - Market size and forecast 2024-2029 ($ billion)
- Data Table on NLP - Market size and forecast 2024-2029 ($ billion)
- Chart on NLP - Year-over-year growth 2024-2029 (%)
- Data Table on NLP - Year-over-year growth 2024-2029 (%)
- 8.5 Machine learning - Market size and forecast 2024-2029
- Chart on Machine learning - Market size and forecast 2024-2029 ($ billion)
- Data Table on Machine learning - Market size and forecast 2024-2029 ($ billion)
- Chart on Machine learning - Year-over-year growth 2024-2029 (%)
- Data Table on Machine learning - Year-over-year growth 2024-2029 (%)
- 8.6 Robotic process automation - Market size and forecast 2024-2029
- Chart on Robotic process automation - Market size and forecast 2024-2029 ($ billion)
- Data Table on Robotic process automation - Market size and forecast 2024-2029 ($ billion)
- Chart on Robotic process automation - Year-over-year growth 2024-2029 (%)
- Data Table on Robotic process automation - Year-over-year growth 2024-2029 (%)
- 8.7 Market opportunity by Technology
- Market opportunity by Technology ($ billion)
- Data Table on Market opportunity by Technology ($ billion)
9 Market Segmentation by End-user
- 9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Pharmaceutical companies - Market size and forecast 2024-2029
- Chart on Pharmaceutical companies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Pharmaceutical companies - Market size and forecast 2024-2029 ($ billion)
- Chart on Pharmaceutical companies - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmaceutical companies - Year-over-year growth 2024-2029 (%)
- 9.4 Biotechnology companies - Market size and forecast 2024-2029
- Chart on Biotechnology companies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Biotechnology companies - Market size and forecast 2024-2029 ($ billion)
- Chart on Biotechnology companies - Year-over-year growth 2024-2029 (%)
- Data Table on Biotechnology companies - Year-over-year growth 2024-2029 (%)
- 9.5 Contract research organizations - Market size and forecast 2024-2029
- Chart on Contract research organizations - Market size and forecast 2024-2029 ($ billion)
- Data Table on Contract research organizations - Market size and forecast 2024-2029 ($ billion)
- Chart on Contract research organizations - Year-over-year growth 2024-2029 (%)
- Data Table on Contract research organizations - Year-over-year growth 2024-2029 (%)
- 9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
10 Customer Landscape
- 10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 11.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 11.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 11.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 11.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 11.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 11.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 11.4.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 11.4.5 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 11.4.6 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 11.5 APAC - Market size and forecast 2024-2029
- Chart on APAC - Market size and forecast 2024-2029 ($ billion)
- Data Table on APAC - Market size and forecast 2024-2029 ($ billion)
- Chart on APAC - Year-over-year growth 2024-2029 (%)
- Data Table on APAC - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - APAC
- Data Table on Regional Comparison - APAC
- 11.5.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 11.5.2 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 11.5.3 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 11.5.4 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 11.5.5 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 11.5.6 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 11.6 South America - Market size and forecast 2024-2029
- Chart on South America - Market size and forecast 2024-2029 ($ billion)
- Data Table on South America - Market size and forecast 2024-2029 ($ billion)
- Chart on South America - Year-over-year growth 2024-2029 (%)
- Data Table on South America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - South America
- Data Table on Regional Comparison - South America
- 11.6.1 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 11.6.2 Argentina - Market size and forecast 2024-2029
- Chart on Argentina - Market size and forecast 2024-2029 ($ billion)
- Data Table on Argentina - Market size and forecast 2024-2029 ($ billion)
- Chart on Argentina - Year-over-year growth 2024-2029 (%)
- Data Table on Argentina - Year-over-year growth 2024-2029 (%)
- 11.6.3 Colombia - Market size and forecast 2024-2029
- Chart on Colombia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Colombia - Market size and forecast 2024-2029 ($ billion)
- Chart on Colombia - Year-over-year growth 2024-2029 (%)
- Data Table on Colombia - Year-over-year growth 2024-2029 (%)
- 11.7 Middle East and Africa - Market size and forecast 2024-2029
- Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Middle East and Africa
- Data Table on Regional Comparison - Middle East and Africa
- 11.7.1 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 11.7.2 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 11.7.3 Israel - Market size and forecast 2024-2029
- Chart on Israel - Market size and forecast 2024-2029 ($ billion)
- Data Table on Israel - Market size and forecast 2024-2029 ($ billion)
- Chart on Israel - Year-over-year growth 2024-2029 (%)
- Data Table on Israel - Year-over-year growth 2024-2029 (%)
- 11.7.4 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 11.7.5 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 11.8 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
12 Drivers, Challenges, and Opportunity
- 12 Drivers, Challenges, and Opportunity
- 12.1 Market drivers
- Escalating volume and complexity of clinical and real-world data
- Imperative to accelerate drug development timelines and mitigate costs
- Maturation and proliferation of advanced natural language processing and generative AI
- 12.2 Market challenges
- Ensuring data privacy and security in a highly regulated environment
- Navigating complex regulatory and ethical landscapes
- Maintaining scientific accuracy and mitigating hallucinations
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities
- Development and adoption of domain-specific large language models
- Integration of AI into end-to-end regulatory and clinical platforms
- Focus on hyper-automation of repetitive and template-driven documentation
13 Competitive Landscape
- 13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14 Competitive Analysis
- 14.1 Companies profiled
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 AINGENS
- AINGENS - Overview
- AINGENS - Product / Service
- AINGENS - Key offerings
- SWOT
- 14.5 Artos
- Artos - Overview
- Artos - Product / Service
- Artos - Key offerings
- SWOT
- 14.6 Cactus Communications Pvt. Ltd.
- Cactus Communications Pvt. Ltd. - Overview
- Cactus Communications Pvt. Ltd. - Product / Service
- Cactus Communications Pvt. Ltd. - Key offerings
- SWOT
- 14.7 Certara Inc.
- Certara Inc. - Overview
- Certara Inc. - Product / Service
- Certara Inc. - Key offerings
- SWOT
- 14.8 GENINVO
- GENINVO - Overview
- GENINVO - Product / Service
- GENINVO - Key offerings
- SWOT
- 14.9 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
- 14.10 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
- 14.11 OpenAI
- OpenAI - Overview
- OpenAI - Product / Service
- OpenAI - Key offerings
- SWOT
- 14.12 Oracle Corp.
- Oracle Corp. - Overview
- Oracle Corp. - Business segments
- Oracle Corp. - Key news
- Oracle Corp. - Key offerings
- Oracle Corp. - Segment focus
- SWOT
- 14.13 Parexel International Corp.
- Parexel International Corp. - Overview
- Parexel International Corp. - Product / Service
- Parexel International Corp. - Key offerings
- SWOT
- 14.14 SAS Institute Inc.
- SAS Institute Inc. - Overview
- SAS Institute Inc. - Product / Service
- SAS Institute Inc. - Key news
- SAS Institute Inc. - Key offerings
- SWOT
- 14.15 Scite LLC
- Scite LLC - Overview
- Scite LLC - Product / Service
- Scite LLC - Key offerings
- SWOT
- 14.16 Syneos Health
- Syneos Health - Overview
- Syneos Health - Product / Service
- Syneos Health - Key offerings
- SWOT
- 14.17 TrialAssure
- TrialAssure - Overview
- TrialAssure - Product / Service
- TrialAssure - Key offerings
- SWOT
- 14.18 Veeva Systems Inc.
- Veeva Systems Inc. - Overview
- Veeva Systems Inc. - Business segments
- Veeva Systems Inc. - Key offerings
- Veeva Systems Inc. - Segment focus
- SWOT
15 Appendix
- 15 Appendix
- 15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.5 Data procurement
- 15.6 Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
